3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Not yet recruiting
3
Terminated
1
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
682
Neoplasms
594
Carcinoma, Non-Small-Cell Lung
293
Colorectal Neoplasms
292
Prostatic Neoplasms
284
Lung Neoplasms
224
Melanoma
161
Multiple Myeloma
151
Neoplasm Metastasis
146
Pancreatic Neoplasms
143
Head and Neck Neoplasms
143
Ovarian Neoplasms
136
Carcinoma, Hepatocellular
126
Leukemia, Myeloid, Acute
123
Colonic Neoplasms
114
Brain Neoplasms
113
Squamous Cell Carcinoma of Head and Neck
111
Uterine Cervical Neoplasms
109
Stomach Neoplasms
106
Recurrence
101
Lymphoma
101
Glioblastoma
96
Precursor Cell Lymphoblastic Leukemia-Lymphoma
83
Lymphoma, Non-Hodgkin
82
Hematologic Neoplasms
80
Urinary Bladder Neoplasms
78
Lymphoma, Follicular
78
Glioma
77
Parkinson Disease 4, Autosomal Dominant Lewy Body
74
Sarcoma
72
Interventions
Raltegravir Potassium
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Hepatic Insufficiency
×
1 year
×
Clear all
NCT01022476
2026-04-06
LIVERAL
ANRS, Emerging Infectious Diseases
Phase 1/2
Completed
14 enrolled